These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35114276)

  • 41. Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss.
    Baudino TA; Maclean KH; Brennan J; Parganas E; Yang C; Aslanian A; Lees JA; Sherr CJ; Roussel MF; Cleveland JL
    Mol Cell; 2003 Apr; 11(4):905-14. PubMed ID: 12718877
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RUNX1 and its fusion oncoprotein derivative, RUNX1-ETO, induce senescence-like growth arrest independently of replicative stress.
    Wolyniec K; Wotton S; Kilbey A; Jenkins A; Terry A; Peters G; Stocking C; Cameron E; Neil JC
    Oncogene; 2009 Jul; 28(27):2502-12. PubMed ID: 19448675
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The over-expression of miR-34a fails to block DoHH2 lymphoma cell proliferation by reducing p53 via c-MYC down-regulation.
    Rizzo M; Mariani L; Cavallini S; Simili M; Rainaldi G
    Nucleic Acid Ther; 2012 Aug; 22(4):283-8. PubMed ID: 22830357
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential synergism of Bim with p53 in mice with Myc‑induced lymphoma in a mouse lymphoma model.
    Shang Q; Zhang D; Guo C; Lin Q; Guo Z; Deng C
    Mol Med Rep; 2012 Jun; 5(6):1401-8. PubMed ID: 22446994
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Loss of a Single Mcl-1 Allele Inhibits MYC-Driven Lymphomagenesis by Sensitizing Pro-B Cells to Apoptosis.
    Grabow S; Delbridge AR; Aubrey BJ; Vandenberg CJ; Strasser A
    Cell Rep; 2016 Mar; 14(10):2337-47. PubMed ID: 26947081
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.
    Eischen CM; Roussel MF; Korsmeyer SJ; Cleveland JL
    Mol Cell Biol; 2001 Nov; 21(22):7653-62. PubMed ID: 11604501
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pim-1 kinase phosphorylates RUNX family transcription factors and enhances their activity.
    Aho TL; Sandholm J; Peltola KJ; Ito Y; Koskinen PJ
    BMC Cell Biol; 2006 May; 7():21. PubMed ID: 16684349
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RUNX1 transformation of primary embryonic fibroblasts is revealed in the absence of p53.
    Wotton SF; Blyth K; Kilbey A; Jenkins A; Terry A; Bernardin-Fried F; Friedman AD; Baxter EW; Neil JC; Cameron ER
    Oncogene; 2004 Jul; 23(32):5476-86. PubMed ID: 15133495
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Runx2: a novel oncogenic effector revealed by in vivo complementation and retroviral tagging.
    Blyth K; Terry A; Mackay N; Vaillant F; Bell M; Cameron ER; Neil JC; Stewart M
    Oncogene; 2001 Jan; 20(3):295-302. PubMed ID: 11313958
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Runx genes: lineage-specific oncogenes and tumor suppressors.
    Cameron ER; Neil JC
    Oncogene; 2004 May; 23(24):4308-14. PubMed ID: 15156187
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Moloney murine leukemia virus-induced lymphomas in p53-deficient mice: overlapping pathways in tumor development?
    Baxter EW; Blyth K; Donehower LA; Cameron ER; Onions DE; Neil JC
    J Virol; 1996 Apr; 70(4):2095-100. PubMed ID: 8642629
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase.
    Shreeram S; Hee WK; Demidov ON; Kek C; Yamaguchi H; Fornace AJ; Anderson CW; Appella E; Bulavin DV
    J Exp Med; 2006 Dec; 203(13):2793-9. PubMed ID: 17158963
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FOXM1 allows human keratinocytes to bypass the oncogene-induced differentiation checkpoint in response to gain of MYC or loss of p53.
    Molinuevo R; Freije A; de Pedro I; Stoll SW; Elder JT; Gandarillas A
    Oncogene; 2017 Feb; 36(7):956-965. PubMed ID: 27452522
    [TBL] [Abstract][Full Text] [Related]  

  • 54. RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells.
    van Bragt MP; Hu X; Xie Y; Li Z
    Elife; 2014 Nov; 3():e03881. PubMed ID: 25415051
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Runx genes as dominant oncogenes.
    Cameron ER; Blyth K; Hanlon L; Kilbey A; Mackay N; Stewart M; Terry A; Vaillant F; Wotton S; Neil JC
    Blood Cells Mol Dis; 2003; 30(2):194-200. PubMed ID: 12732183
    [TBL] [Abstract][Full Text] [Related]  

  • 56. RUNX3 and p53: How Two Tumor Suppressors Cooperate Against Oncogenic Ras?
    Lee JW; van Wijnen A; Bae SC
    Adv Exp Med Biol; 2017; 962():321-332. PubMed ID: 28299666
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic regulation of the RUNX transcription factor family has antitumor effects.
    Morita K; Suzuki K; Maeda S; Matsuo A; Mitsuda Y; Tokushige C; Kashiwazaki G; Taniguchi J; Maeda R; Noura M; Hirata M; Kataoka T; Yano A; Yamada Y; Kiyose H; Tokumasu M; Matsuo H; Tanaka S; Okuno Y; Muto M; Naka K; Ito K; Kitamura T; Kaneda Y; Liu PP; Bando T; Adachi S; Sugiyama H; Kamikubo Y
    J Clin Invest; 2017 Jun; 127(7):2815-2828. PubMed ID: 28530640
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blockage of Glyoxalase I Inhibits Colorectal Tumorigenesis and Tumor Growth via Upregulation of STAT1, p53, and Bax and Downregulation of c-Myc and Bcl-2.
    Chen Y; Fang L; Zhang J; Li G; Ma M; Li C; Lyu J; Meng QH
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28282916
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Runx2 and MYC collaborate in lymphoma development by suppressing apoptotic and growth arrest pathways in vivo.
    Blyth K; Vaillant F; Hanlon L; Mackay N; Bell M; Jenkins A; Neil JC; Cameron ER
    Cancer Res; 2006 Feb; 66(4):2195-201. PubMed ID: 16489021
    [TBL] [Abstract][Full Text] [Related]  

  • 60. p53 Activates the Long Noncoding RNA Pvt1b to Inhibit Myc and Suppress Tumorigenesis.
    Olivero CE; Martínez-Terroba E; Zimmer J; Liao C; Tesfaye E; Hooshdaran N; Schofield JA; Bendor J; Fang D; Simon MD; Zamudio JR; Dimitrova N
    Mol Cell; 2020 Feb; 77(4):761-774.e8. PubMed ID: 31973890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.